Scientists reprogram Patient's own cells to hunt cancer
NCT ID NCT00923806
Summary
This was an early-stage study testing a new gene therapy for advanced cancer that had spread. Doctors took a patient's own white blood cells, genetically modified them in a lab to recognize a specific protein found on cancer cells, and then infused them back into the patient. The goal was to see if these 're-trained' immune cells could safely shrink tumors in patients who had run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.